Subtotal Cholecystectomy for Difficult Gall Bladder Due to Chronic Cholecystitis
1 other identifier
observational
1,149
1 country
1
Brief Summary
Subtotal cholecystectomy (STC) is a valuable technique when severe inflammation, fibrosis, or anatomical variations obscure the critical view of safety essential for identifying the cystic duct and artery. It helps reduce the risk of bile duct injuries and other complications that arise during a total cholecystectomy (TC) when these structures are not visible. This study evaluates the safety and outcomes of subtotal cholecystectomy in chronic cholecystitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2025
CompletedFirst Submitted
Initial submission to the registry
January 27, 2025
CompletedFirst Posted
Study publicly available on registry
May 13, 2025
CompletedMay 13, 2025
January 1, 2025
20 days
January 27, 2025
May 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative outcomes of subtotal cholecystectomy (STC) and total cholecystectomy (TC)
The primary outcome was to assess the postoperative outcomes of subtotal cholecystectomy (STC) and total cholecystectomy (TC) groups.
upto 22 months
Interventions
The indications for elective cholecystectomy were symptomatic cholelithiasis, a GB polyp more than ten millimeters, a history of cholecystitis, biliary pancreatitis, or choledocholithiasis. Patients with cholecystitis and severe or moderately severe pancreatitis were operated on after six weeks of the event. Other patients received surgery at the earliest available date. All patients with choledocholithiasis underwent endoscopic retrograde cholangiopancreatography (ERCP) and stone clearance before cholecystectomy. Patients who underwent laparoscopic cholecystectomy were evaluated by surgical and anesthesia teams in outpatient clinics and co-morbid conditions were optimized. Preoperative antibiotic prophylaxis was given to all the patients before induction of anesthesia.
Eligibility Criteria
patients undergoing laparoscopic cholecystectomy
You may qualify if:
- Clinical diagnosis of cholelithiasis planned for laparoscopic cholecystectomy
- Clinical diagnosis of gallbladder polyp planned for laparoscopic cholecystectomy
You may not qualify if:
- Gall bladder malignancy
- Cholelithiasis and gallbladder polyp cases managed non-operatively
- additional procedures along with cholecystectomy like bile duct exploration, bile duct excision for choledochal cyst.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tribhuvan University Teaching Hospital, Kathmandu, Nepal
Kathmandu, 44600, Nepal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 27, 2025
First Posted
May 13, 2025
Study Start
December 23, 2024
Primary Completion
January 12, 2025
Study Completion
January 13, 2025
Last Updated
May 13, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- as supplementary file
- Access Criteria
- as supplementary file
apart from identifiers, relevant clinical data.